Rockwell Medical Inc. [NASDAQ: RMTI] jumped around 0.13 points on Friday, while shares priced at $1.06 at the close of the session, up 13.87%. The company report on April 23, 2021 that Rockwell Medical Presents Data on Diagnosis and Management of Iron Deficiency Anemia in Home Parenteral Nutrition Patients at the NHIA 2021 Annual Conference.
Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, announced that it presented data from a clinical feasibility study reviewing the practice patterns of iron deficiency anemia (IDA) in home parenteral nutrition patients at the National Home Infusion Association’s (NHIA) 2021 Annual Conference, taking place virtually from April 19 to 22, 2021.
“The study results validated our initial assumptions that management of iron deficiency anemia in this home infusion population is suboptimal and remains an unmet clinical need. Although approximately half of the patients in the home infusion setting suffer from iron deficiency anemia, and oral iron is indicated as a first-line therapy, many patients may not tolerate it, or may have unsatisfactory results with this option,” said Marc L. Hoffman, M.D., Chief Medical Officer of Rockwell Medical and study author. “Traditional forms of IV iron are rarely administered unsupervised in the home due to risk of hypersensitivity reactions or concerns about incompatibility with other medications, and office visits for infusion of IV iron are costly, inconvenient, and often do not fit the physician practice care model.”.
Rockwell Medical Inc. stock is now 4.95% up from its year-to-date (YTD) trading value. RMTI Stock saw the intraday high of $1.20 and lowest of $0.9302 per share. The company’s 52-week high price is 2.53, which means current price is +21.84% above from all time high which was touched on 02/09/21.
Compared to the average trading volume of 2.15M shares, RMTI reached a trading volume of 11391284 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Rockwell Medical Inc. [RMTI]?
Piper Jaffray have made an estimate for Rockwell Medical Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on June 24, 2019. While these analysts kept the previous recommendation, H.C. Wainwright raised their target price to Buy. The new note on the price target was released on May 13, 2019, representing the official price target for Rockwell Medical Inc. stock.
The Average True Range (ATR) for Rockwell Medical Inc. is set at 0.10, with the Price to Sales ratio for RMTI stock in the period of the last 12 months amounting to 1.40. The Price to Book ratio for the last quarter was 2.94, with the Price to Cash per share for the same quarter was set at 0.71.
How has RMTI stock performed recently?
Rockwell Medical Inc. [RMTI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.51. With this latest performance, RMTI shares dropped by -9.40% in over the last four-week period, additionally plugging by 4.95% over the last 6 months – not to mention a drop of -54.11% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RMTI stock in for the last two-week period is set at 48.48, with the RSI for the last a single of trading hit 56.30, and the three-weeks RSI is set at 46.09 for Rockwell Medical Inc. [RMTI]. The present Moving Average for the last 50 days of trading for this stock 1.2583, while it was recorded at 0.9440 for the last single week of trading, and 1.2710 for the last 200 days.
Rockwell Medical Inc. [RMTI]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Rockwell Medical Inc. [RMTI] shares currently have an operating margin of -45.69 and a Gross Margin at +4.38. Rockwell Medical Inc.’s Net Margin is presently recorded at -49.66.
Return on Total Capital for RMTI is now -68.93, given the latest momentum, and Return on Invested Capital for the company is -78.16. Return on Equity for this stock declined to -113.38, with Return on Assets sitting at -50.61. When it comes to the capital structure of this company, Rockwell Medical Inc. [RMTI] has a Total Debt to Total Equity ratio set at 70.05. Additionally, RMTI Total Debt to Total Capital is recorded at 41.19, with Total Debt to Total Assets ending up at 30.79. Long-Term Debt to Equity for the company is recorded at 66.64, with the Long-Term Debt to Total Capital now at 39.19.
Reflecting on the efficiency of the workforce at the company, Rockwell Medical Inc. [RMTI] managed to generate an average of -$102,967 per employee. Receivables Turnover for the company is 14.86 with a Total Asset Turnover recorded at a value of 1.02.Rockwell Medical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.10 and a Current Ratio set at 5.40.
Earnings analysis for Rockwell Medical Inc. [RMTI]
With the latest financial reports released by the company, Rockwell Medical Inc. posted -0.12/share EPS, while the average EPS was predicted by analysts to be reported at -0.12/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for RMTI. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Rockwell Medical Inc. go to 38.00%.
Insider trade positions for Rockwell Medical Inc. [RMTI]
There are presently around $23 million, or 41.40% of RMTI stock, in the hands of institutional investors. The top three institutional holders of RMTI stocks are: BLACKROCK INC. with ownership of 4,790,950, which is approximately 5.921% of the company’s market cap and around 0.30% of the total institutional ownership; VANGUARD GROUP INC, holding 2,788,460 shares of the stock with an approximate value of $2.96 million in RMTI stocks shares; and PERKINS CAPITAL MANAGEMENT INC, currently with $2.6 million in RMTI stock with ownership of nearly 33.25% of the company’s market capitalization.
Positions in Rockwell Medical Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 48 institutional holders increased their position in Rockwell Medical Inc. [NASDAQ:RMTI] by around 4,172,245 shares. Additionally, 27 investors decreased positions by around 7,603,408 shares, while 25 investors held positions by with 9,787,783 shares. The mentioned changes placed institutional holdings at 21,563,436 shares, according to the latest SEC report filing. RMTI stock had 14 new institutional investments in for a total of 612,587 shares, while 8 institutional investors sold positions of 169,991 shares during the same period.